Literature DB >> 18480449

The cytoplasmic terminus of Kaposi's sarcoma-associated herpesvirus glycoprotein B is not essential for virion egress and infectivity.

R Subramanian1, O D'Auvergne, Haixia Kong, K G Kousoulas.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded glycoprotein B (gB) is an important determinant of viral infectivity and virion egress. A small interfering RNA (siRNA)-based strategy was devised to inhibit KSHV gB gene expression. Transient cotransfection of plasmids constitutively expressing gB and anti-gB siRNAs in 293 cells substantially inhibited gB mRNA levels and protein production. Similarly, transient expression of siRNAs into the primary effusion lymphoma cell line BCBL-1 caused a substantial reduction of gB transcripts and protein synthesis. TaqMan real-time PCR assays against the lytic KSHV gene ORF59 and infectivity assays on 293 cells were employed to assess the effect of inhibiting gB synthesis on virion egress from BCBL-1 cells and infectivity on 293 cells, respectively. These experiments showed that gB was essential for virion egress and infectivity. Transfection of a codon-optimized gB gene with the first 540 nucleotides altered, and therefore not recognized by anti-gB siRNAs that target the native but not the codon-optimized sequence, efficiently rescued virion egress and infectivity in BCBL-1 cells in the presence of siRNAs inhibiting wild-type gB expression. To assess the role of the cytoplasmic domain of gB in virion egress, mutant gB genes were generated specifying carboxyl terminal truncations of 25 and 58 amino acids disrupting two prominent predicted alpha-helical domains associated with virus-induced cell fusion. A third truncation removed the entire predicted cytoplasmic terminus of 84 amino acids, while a fourth truncation removed 110 amino acids, including the terminal most hydrophobic, intramembrane anchoring sequence. Virion egress experiments revealed that all truncated gBs facilitated virion egress from BCBL-1 cells, with the exception of the largest 110-amino-acid truncation, which removed the gB anchoring sequence. Importantly, the gB truncation that removed the entire predicted cytoplasmic domain increased virion egress, suggesting the presence of a egress regulation domain located proximal to the intramembrane sequence within the cytoplasmic domain of gB. All supernatant virions were infectious on 293 cells, indicating that the carboxyl terminus of gB is not essential for either virion egress or virus infectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480449      PMCID: PMC2446944          DOI: 10.1128/JVI.00617-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Epstein-Barr virus enters B cells and epithelial cells by different routes.

Authors:  N Miller; L M Hutt-Fletcher
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 2.  Strategies for silencing human disease using RNA interference.

Authors:  Daniel H Kim; John J Rossi
Journal:  Nat Rev Genet       Date:  2007-03       Impact factor: 53.242

Review 3.  Function of glycoprotein B homologues of the family herpesviridae.

Authors:  L Pereira
Journal:  Infect Agents Dis       Date:  1994-02

4.  Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110.

Authors:  M Gong; E Kieff
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae.

Authors:  P S Moore; S J Gao; G Dominguez; E Cesarman; O Lungu; D M Knowles; R Garber; P E Pellett; D J McGeoch; Y Chang
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

6.  Genetic relationships between bovine herpesvirus 4 and the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri.

Authors:  M Bublot; P Lomonte; A S Lequarre; J C Albrecht; J Nicholas; B Fleckenstein; P P Pastoret; E Thiry
Journal:  Virology       Date:  1992-10       Impact factor: 3.616

7.  Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface.

Authors:  T Compton; R R Nepomuceno; D M Nowlin
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

8.  Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion.

Authors:  A Baghian; L Huang; S Newman; S Jayachandra; K G Kousoulas
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion.

Authors:  B Peeters; N de Wind; M Hooisma; F Wagenaar; A Gielkens; R Moormann
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells.

Authors:  E A Mesri; E Cesarman; L Arvanitakis; S Rafii; M A Moore; D N Posnett; D M Knowles; A S Asch
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  6 in total

1.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

2.  Functional hierarchy of herpes simplex virus 1 viral glycoproteins in cytoplasmic virion envelopment and egress.

Authors:  Dmitry V Chouljenko; In-Joong Kim; Vladimir N Chouljenko; Ramesh Subramanian; Jason D Walker; Konstantin G Kousoulas
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

3.  Herpes simplex virus glycoproteins gB and gD function in a redundant fashion to promote secondary envelopment.

Authors:  David C Johnson; Todd W Wisner; Catherine C Wright
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells.

Authors:  R Subramanian; I Sehgal; O D'Auvergne; K G Kousoulas
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

5.  A herpes simplex virus 1 (McKrae) mutant lacking the glycoprotein K gene is unable to infect via neuronal axons and egress from neuronal cell bodies.

Authors:  Andrew T David; Ahmad Saied; Anu Charles; Ramesh Subramanian; Vladimir N Chouljenko; Konstantin G Kousoulas
Journal:  MBio       Date:  2012-07-24       Impact factor: 7.867

6.  The Kaposi's Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals.

Authors:  Yasaman Mortazavi; Salum J Lidenge; Tara Tran; John T West; Charles Wood; For Yue Tso
Journal:  Viruses       Date:  2020-02-26       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.